Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Thalidomide for the Treatment of Covid-19 Pneumonia: A Randomized Controlled Clinical Trial Publisher



Amra B1 ; Ashrafi F2 ; Torki M3 ; Hashemi M3 ; Shirzadi M3 ; Soltaninejad F1 ; Sadeghi S3 ; Salmasi M3 ; Sami R3 ; Darakhshandeh A3 ; Nasirian M4 ; Pourajam S3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Bamdad Respiratory and Sleep Research Center, Department of Internal Medicine, Pulmonary and Sleep Ward, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Hematology Oncology, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Epidemiology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Advanced Biomedical Research Published:2023


Abstract

Background: Coronavirus disease 2019 has become a public health concern with a high number of fatalities. Thalidomide can target inflammatory mediators and decrease inflammation in SARS-CoV-2. Materials and Methods: An open-label, randomized controlled trial was conducted on patients with compatible lung high-resolution computed tomography scan for COVID-19 pneumonia and moderate involvement. Childbearing-Age women were excluded. A total of 20 patients in the control group receiving usual treatment were compared with 26 patients in the case group who in addition to the same regimen also received thalidomide. The primary outcome was time for clinical recovery (TTCR) and intensive-care unit (ICU) admission. Results: From April 25 to August 8, 2020, based on the inclusion criteria, 47 patients were assigned to the study. Patients receiving thalidomide had a mean TTCR of days 5.5 (95% confidence interval [CI], 0.7-10.3), as compared with days 5.3 (95% CI, 1.7-8.9) with control (odds ratio 0.01; 95% CI,-1.58-1.59, P = 0.807). The incidence of ICU admission was 27% in the thalidomide group compared with 20% in the control group (odds ratio 3.89; 95% CI, 0.55-27.4, P = 0.425). The mean length of stay in hospital in both groups was 10 days. Progressive improvement in respiratory rate, fever, and O 2 saturation during the study was seen in both groups without a significant difference between the thalidomide and control group (P > 0.05). Conclusion: This study investigated the effects of thalidomide to treat moderate COVID-19 clinical outcomes. The results established that this drug regimen did not add more effect to usual treatment for moderate COVID-19 pneumonia. © 2023 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
2. Hemoperfusion in Patients With Severe Covid-19 Respiratory Failure, Lifesaving or Not?, Journal of Research in Medical Sciences (2021)
3. On Admission Hemoglobin and Albumin, As the Two Novel Factors Associated With Thrombosis in Covid-19 Pneumonia, Journal of Renal Injury Prevention (2022)
4. Chest Computed Tomography Severity Score to Predict Adverse Outcomes of Patients With Covid-19, Infection and Chemotherapy (2021)
5. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
6. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
7. The Correlation Between Viral Shedding Duration and Blood Biomarkers in Covid-19-Infected Patients, Journal of Research in Medical Sciences (2022)
8. Physiologic Scoring Systems in Predicting the Covid-19 Patients’ One-Month Mortality; a Prognostic Accuracy Study, Archives of Academic Emergency Medicine (2022)
Experts (# of related papers)
View all Related Experts
Ramin Sami (14)
Marjan Mansourian (8)
Other Related Docs
9. Risk Factors of Pulmonary Complications in Patients With Covid-19: A Case-Control Study, Archives of Clinical Infectious Diseases (2024)
10. Severity of Disease and Covid-19 Complications During Hospital Stay: A Prospective Cohort Study, Archives of Iranian Medicine (2022)
11. Low Dose Radiation Therapy for Covid-19 Pneumonia: A Double-Edged Sword, Radiotherapy and Oncology (2020)
12. The Impact of Covid-19 Pandemic on Neuromyelitis Optica Disorder Patients, After One Year, Caspian Journal of Neurological Sciences (2022)
13. A Systematic Review on Post-Discharge Venous Thromboembolism Prophylaxis in Patients With Covid-19, Egyptian Heart Journal (2023)
14. The Demographic, Clinical, and Medical Manifestations of Pulmonary Thromboembolism Development in Covid-19, Blood Research (2021)
15. The Relationship Between Ct Severity Score and Capillary Blood Oxygen Saturation in Patients With Covid-19 Infection, Indian Journal of Critical Care Medicine (2021)
16. Covid-19 Infection Rate After Urgent Versus Elective Total Hip Replacement Among Unvaccinated Individuals: A Multicenter Prospective Cohort Amid the Covid-19 Pandemic, Annals of Medicine and Surgery (2022)
17. Adrenal Insufficiency in Coronavirus Disease 2019 (Covid-19)-Infected Patients Without Preexisting Adrenal Diseases: A Systematic Literature Review, International Journal of Endocrinology (2021)
18. Bacterial Infections and Outcomes of Inpatients With Covid-19 in the Intensive Care Unit During the Delta-Dominant Phase: The Worst Wave of Pandemic in Iran, Frontiers in Public Health (2024)
19. A Review of Pathophysiological Mechanism, Diagnosis, and Treatment of Thrombosis Risk Associated With Covid-19 Infection, IJC Heart and Vasculature (2022)
20. Comparison of Clinical Outcomes, Demographic, and Laboratory Characteristics of Hospitalized Covid-19 Patients During Major Three Waves Driven by Alpha, Delta, and Omicron Variants in Tehran, Iran, Influenza and other Respiratory Viruses (2023)
21. Is Non-Invasive Ventilation a Good Choice in All Patients With Severe Covid-19? a Cohort Retrospective Study, Tanaffos (2024)
22. Covid-19 and the Potential of Janus Family Kinase (Jak) Pathway Inhibition: A Novel Treatment Strategy, Frontiers in Medicine (2022)
23. Hemoperfusion As a Supportive Treatment in a Covid-19 Patient With Late Pulmonary Thromboembolism: A Case Report, International Medical Case Reports Journal (2020)
24. Risk Factors Associated With Intensive Care Unit (Icu) Admission and In-Hospital Death Among Adults Hospitalized With Covid-19: A Two-Center Retrospective Observational Study in Tertiary Care Hospitals, Emergency Radiology (2021)
25. Covid-19 Pneumonia and Pulmonary Embolism: Presentation of Four Cases, Indian Journal of Critical Care Medicine (2020)
26. T-Cell Immunophenotyping in Covid-19 Pneumonia, Journal of Research in Medical Sciences (2021)
27. Safety and Efficacy of Favipiravir in Moderate to Severe Sars-Cov-2 Pneumonia, International Immunopharmacology (2021)
28. Potential Immune Indicators for Predicting the Prognosis of Covid-19 and Trauma: Similarities and Disparities, Frontiers in Immunology (2022)
29. Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran, Future Virology (2021)
30. On-Admission Versus In-Hospital Thromboembolism Due to Covid-19 Infection. What Is the Particular Characteristic of Those With Early Thrombotic Events?, Advances in Respiratory Medicine (2021)
31. An Investigation to Find the Correlation Between Lupus Anticoagulant and Coagulation Abnormalities in Covid-19 Patients; a Narrative Review, Journal of Nephropathology (2024)
32. Association of Systemic Complications With Mortality in Coronavirus Disease of 2019: A Cohort Study on Intensive Care Unit Patients, Journal of Research in Medical Sciences (2022)
33. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
34. Bacterial Superinfection and Antibiotic Management in Patients With Covid-19 Admitted to Intensive Care Medicine in Central Iran: A Follow-Up Study, Advanced Biomedical Research (2023)
35. Radiological Findings As Predictors of Covid-19 Lung Sequelae: A Systematic Review and Meta-Analysis, Academic Radiology (2023)
36. Iranian Pediatric Covid-19 Epidemiology and Clinical Characteristics, Canadian Journal of Infectious Diseases and Medical Microbiology (2021)
37. Immune System Changes During Covid-19 Recovery Play Key Role in Determining Disease Severity, International Journal of Immunopathology and Pharmacology (2020)
38. Differential Diagnostic Utility of Clinical Laboratory Data in Patients With Severe and Non-Severe Covid-19, Shiraz E Medical Journal (2022)
39. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
40. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
41. Secondary Bacterial Infection and Clinical Characteristics in Patients With Covid-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic, Frontiers in Cellular and Infection Microbiology (2022)
42. Effect of Curcumin-Pipeine Supplementation on Clinical Status, Mortality Rate, Oxidative Stress, and Inflammatory Markers in Critically Ill Icu Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomized Controlled Trial, Trials (2021)
43. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
44. The Value of Thoracic Computed Tomography Scan Comparing to Reverse Transcription-Polymerase Chain Reaction for the Diagnosis of Covid-19, Journal of Research in Medical Sciences (2021)
45. Outcomes of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase, Stroke (2022)
46. The Severity of Symptoms and Outcomes of Patients Admitted With Rheumatic Diseases and Covid-19; a Prospective Cohort Study in Iran, Immunopathologia Persa (2021)
47. Association Between Clinical Characteristics and Laboratory Findings With Outcome of Hospitalized Covid-19 Patients: A Report From Northeast Iran, Interdisciplinary Perspectives on Infectious Diseases (2021)
48. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
49. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
50. Covid-19, an Early Investigation From Exposure to Treatment Outcomes in Tehran, Iran, Journal of Research in Medical Sciences (2021)